Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI
Tempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously founded Groupon, debuted on Nasdaq on Friday, rising about 15% on the opening. The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully diluted […] © 2024 TechCrunch. All rights reserved. For personal use only.
![Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI](https://techcrunch.com/wp-content/uploads/2024/05/Eric-Lefkofsky-1.jpg?resize=1200,800)
Tempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously founded Groupon, debuted on Nasdaq on Friday, rising about 15% on the opening. The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully diluted […]
© 2024 TechCrunch. All rights reserved. For personal use only.
What's Your Reaction?
![like](https://todaypic.com/assets/img/reactions/like.png)
![dislike](https://todaypic.com/assets/img/reactions/dislike.png)
![love](https://todaypic.com/assets/img/reactions/love.png)
![funny](https://todaypic.com/assets/img/reactions/funny.png)
![angry](https://todaypic.com/assets/img/reactions/angry.png)
![sad](https://todaypic.com/assets/img/reactions/sad.png)
![wow](https://todaypic.com/assets/img/reactions/wow.png)